Next Article in Journal
Prognostic Value of Colorectal Cancer Biomarkers
Next Article in Special Issue
X Inactivation and Progenitor Cancer Cells
Previous Article in Journal
Glioma Specific Extracellular Missense Mutations in the First Cysteine Rich Region of Epidermal Growth Factor Receptor (EGFR) Initiate Ligand Independent Activation
Previous Article in Special Issue
Essential Gene Pathways for Glioblastoma Stem Cells: Clinical Implications for Prevention of Tumor Recurrence
Article Menu

Export Article

Open AccessReview
Cancers 2011, 3(2), 2050-2079;

Wnt/β-catenin Signaling in Normal and Cancer Stem Cells

Van Andel Research Institute, 333 Bostwick Ave. N.E., Grand Rapids, MI 49503, USA
Author to whom correspondence should be addressed.
Received: 3 March 2011 / Revised: 12 April 2011 / Accepted: 13 April 2011 / Published: 19 April 2011
(This article belongs to the Special Issue Cancer Stem Cells)
Full-Text   |   PDF [719 KB, uploaded 19 April 2011]


The ability of Wnt ligands to initiate a signaling cascade that results in cytoplasmic stabilization of, and nuclear localization of, β-catenin underlies their ability to regulate progenitor cell differentiation. In this review, we will summarize the current knowledge of the mechanisms underlying Wnt/β-catenin signaling and how the pathway regulates normal differentiation of stem cells in the intestine, mammary gland, and prostate. We will also discuss how dysregulation of the pathway is associated with putative cancer stem cells and the potential therapeutic implications of regulating Wnt signaling. View Full-Text
Keywords: Wnt; β-catenin; stem cells; cancer stem cells; colon; mammary; prostate; therapeutics Wnt; β-catenin; stem cells; cancer stem cells; colon; mammary; prostate; therapeutics
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Valkenburg, K.C.; Graveel, C.R.; Zylstra-Diegel, C.R.; Zhong, Z.; Williams, B.O. Wnt/β-catenin Signaling in Normal and Cancer Stem Cells. Cancers 2011, 3, 2050-2079.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top